Nissay Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16M | Buy |
9,871
+509
| +5% | +$111K | 0.01% | 494 |
|
|
2025
Q1 | $2.1M | Buy |
9,362
+44
| +0.5% | +$9.85K | 0.01% | 503 |
|
|
2024
Q4 | $3.1M | Buy |
9,318
+55
| +0.6% | +$18.3K | 0.02% | 416 |
|
|
2024
Q3 | $2.78M | Buy |
9,263
+257
| +3% | +$77.1K | 0.02% | 446 |
|
|
2024
Q2 | $2.97M | Buy |
9,006
+91
| +1% | +$30K | 0.02% | 405 |
|
|
2024
Q1 | $3.53M | Buy |
8,915
+263
| +3% | +$104K | 0.02% | 372 |
|
|
2023
Q4 | $3.05M | Buy |
8,652
+446
| +5% | +$157K | 0.02% | 365 |
|
|
2023
Q3 | $3.08M | Buy |
8,206
+227
| +3% | +$85.2K | 0.03% | 334 |
|
|
2023
Q2 | $3.05M | Sell |
7,979
-74
| -0.9% | -$28.3K | 0.03% | 349 |
|
|
2023
Q1 | $2.79M | Sell |
8,053
-259
| -3% | -$89.7K | 0.02% | 361 |
|
|
2022
Q4 | $1.96M | Sell |
8,312
-270
| -3% | -$63.5K | 0.02% | 444 |
|
|
2022
Q3 | $2.11M | Buy |
8,582
+249
| +3% | +$61.3K | 0.02% | 408 |
|
|
2022
Q2 | $2.52M | Sell |
8,333
-4,263
| -34% | -$1.29M | 0.03% | 357 |
|
|
2022
Q1 | $5.17M | Sell |
12,596
-1,377
| -10% | -$566K | 0.05% | 244 |
|
|
2021
Q4 | $6.55M | Buy |
13,973
+250
| +2% | +$117K | 0.05% | 212 |
|
|
2021
Q3 | $5.83M | Buy |
13,723
+238
| +2% | +$101K | 0.05% | 214 |
|
|
2021
Q2 | $4.84M | Sell |
13,485
-3,684
| -21% | -$1.32M | 0.04% | 241 |
|
|
2021
Q1 | $4.84M | Buy |
17,169
+4,698
| +38% | +$1.32M | 0.05% | 226 |
|
|
2020
Q4 | $3.53M | Buy |
12,471
+142
| +1% | +$40.2K | 0.05% | 275 |
|
|
2020
Q3 | $3.39M | Sell |
12,329
-9,744
| -44% | -$2.68M | 0.06% | 244 |
|
|
2020
Q2 | $5.01M | Buy |
22,073
+4,753
| +27% | +$1.08M | 0.1% | 199 |
|
|
2020
Q1 | $2.64M | Buy |
17,320
+10,799
| +166% | +$1.64M | 0.07% | 269 |
|
|
2019
Q4 | $980K | Buy |
+6,521
| New | +$980K | 0.02% | 530 |
|